(MCD) McDonald’s - Overview
Stock: Burgers, Chicken, Fries, Beverages, Desserts
| Risk 5d forecast | |
|---|---|
| Volatility | 17.3% |
| Relative Tail Risk | -6.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.32 |
| Alpha | -1.00 |
| Character TTM | |
|---|---|
| Beta | 0.099 |
| Beta Downside | 0.243 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.21% |
| CAGR/Max DD | 0.55 |
EPS (Earnings per Share)
Revenue
Description: MCD McDonald’s March 01, 2026
McDonald’s Corporation (NYSE: MCD) owns, operates, and franchises a global network of restaurants serving a broad menu that includes burgers, chicken sandwiches, breakfast items, coffee, and seasonal promotions. The company’s franchise model spans conventional franchising, developmental licenses, and affiliate arrangements, and it is headquartered in Chicago, Illinois.
Key recent metrics underscore its strength: for Q2 2024, global comparable sales rose 5.0% year-over-year, driven by a 4.2% increase in U.S. same-store sales; the firm reported FY 2023 revenue of $23.2 billion and a dividend yield near 2.5%; and McDonald’s continues to expand digital ordering, which now accounts for roughly 30% of total transactions. Core economic drivers include resilient consumer discretionary spending despite inflationary pressures, and sector-wide trends such as delivery growth and menu innovation that support margin stability.
For a deeper dive into valuation metrics, you might explore ValueRay’s analyst tools.
Headlines to watch out for
- Global comparable sales growth drives revenue
- Franchise royalty fees provide stable income
- Commodity price fluctuations impact food costs
- Labor wage increases pressure operating margins
- Consumer discretionary spending affects demand
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 8.56b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -0.01 > 1.0 |
| NWC/Revenue: -0.74% < 20% (prev 2.85%; Δ -3.58% < -1%) |
| CFO/TA 0.18 > 3% & CFO 10.55b > Net Income 8.56b |
| Net Debt (67.49b) to EBITDA (14.64b): 4.61 < 3 |
| Current Ratio: 0.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (714.2m) vs 12m ago -0.76% < -2% |
| Gross Margin: 57.41% > 18% (prev 0.57%; Δ 5.68k% > 0.5%) |
| Asset Turnover: 46.88% > 50% (prev 46.97%; Δ -0.09% > 0%) |
| Interest Coverage Ratio: 7.89 > 6 (EBITDA TTM 14.64b / Interest Expense TTM 1.58b) |
Altman Z'' 5.21
| A: -0.00 (Total Current Assets 4.16b - Total Current Liabilities 4.36b) / Total Assets 59.52b |
| B: 1.17 (Retained Earnings 69.44b / Total Assets 59.52b) |
| C: 0.22 (EBIT TTM 12.48b / Avg Total Assets 57.35b) |
| D: -0.03 (Book Value of Equity -1.79b / Total Liabilities 61.31b) |
| Altman-Z'' Score: 5.21 = AAA |
Beneish M -3.06
| DSRI: 1.00 (Receivables 2.47b/2.38b, Revenue 26.89b/25.92b) |
| GMI: 0.99 (GM 57.41% / 56.76%) |
| AQI: 0.97 (AQ_t 0.21 / AQ_t-1 0.22) |
| SGI: 1.04 (Revenue 26.89b / 25.92b) |
| TATA: -0.03 (NI 8.56b - CFO 10.55b) / TA 59.52b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of MCD shares?
Over the past week, the price has changed by -0.49%, over one month by +0.21%, over three months by +3.00% and over the past year by +12.27%.
Is MCD a buy, sell or hold?
- StrongBuy: 15
- Buy: 6
- Hold: 15
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MCD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 343.3 | 5.6% |
| Analysts Target Price | 343.3 | 5.6% |
MCD Fundamental Data Overview March 13, 2026
P/E Forward = 24.5098
P/S = 8.5975
P/B = 146.0672
P/EG = 2.8843
Revenue TTM = 26.89b USD
EBIT TTM = 12.48b USD
EBITDA TTM = 14.64b USD
Long Term Debt = 39.97b USD (from longTermDebt, last quarter)
Short Term Debt = 2.50b USD (from shortTermDebt, two quarters ago)
Debt = 68.27b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 67.49b USD (from netDebt column, last quarter)
Enterprise Value = 298.64b USD (231.14b + Debt 68.27b - CCE 774.0m)
Interest Coverage Ratio = 7.89 (Ebit TTM 12.48b / Interest Expense TTM 1.58b)
EV/FCF = 41.56x (Enterprise Value 298.64b / FCF TTM 7.19b)
FCF Yield = 2.41% (FCF TTM 7.19b / Enterprise Value 298.64b)
FCF Margin = 26.73% (FCF TTM 7.19b / Revenue TTM 26.89b)
Net Margin = 31.85% (Net Income TTM 8.56b / Revenue TTM 26.89b)
Gross Margin = 57.41% ((Revenue TTM 26.89b - Cost of Revenue TTM 11.45b) / Revenue TTM)
Gross Margin QoQ = 57.53% (prev 58.00%)
Tobins Q-Ratio = 5.02 (Enterprise Value 298.64b / Total Assets 59.52b)
Interest Expense / Debt = 0.60% (Interest Expense 410.0m / Debt 68.27b)
Taxrate = 21.54% (594.0m / 2.76b)
NOPAT = 9.79b (EBIT 12.48b * (1 - 21.54%))
Current Ratio = 0.95 (Total Current Assets 4.16b / Total Current Liabilities 4.36b)
Debt / Equity = -38.12 (negative equity) (Debt 68.27b / totalStockholderEquity, last quarter -1.79b)
Debt / EBITDA = 4.61 (Net Debt 67.49b / EBITDA 14.64b)
Debt / FCF = 9.39 (Net Debt 67.49b / FCF TTM 7.19b)
Total Stockholder Equity = -2.54b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.93% (Net Income 8.56b / Total Assets 59.52b)
RoE = -336.9% (negative equity) (Net Income TTM 8.56b / Total Stockholder Equity -2.54b)
RoCE = 33.34% (EBIT 12.48b / Capital Employed (Equity -2.54b + L.T.Debt 39.97b))
RoIC = 25.94% (NOPAT 9.79b / Invested Capital 37.74b)
WACC = 4.96% (E(231.14b)/V(299.41b) * Re(6.28%) + D(68.27b)/V(299.41b) * Rd(0.60%) * (1-Tc(0.22)))
Discount Rate = 6.28% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.94%
[DCF] Terminal Value 86.94% ; FCFF base≈6.98b ; Y1≈7.44b ; Y5≈8.94b
[DCF] Fair Price = 277.0 (EV 264.78b - Net Debt 67.49b = Equity 197.29b / Shares 712.2m; r=5.90% [WACC]; 5y FCF grow 7.29% → 2.90% )
EPS Correlation: 68.73 | EPS CAGR: 8.72% | SUE: 0.92 | # QB: 1
Revenue Correlation: 79.41 | Revenue CAGR: 5.84% | SUE: 1.92 | # QB: 1
EPS next Quarter (2026-06-30): EPS=3.43 | Chg7d=+0.000 | Chg30d=-0.038 | Revisions Net=-13 | Analysts=30
EPS current Year (2026-12-31): EPS=13.20 | Chg7d=+0.000 | Chg30d=-0.076 | Revisions Net=-15 | Growth EPS=+8.2% | Growth Revenue=+6.6%
EPS next Year (2027-12-31): EPS=14.32 | Chg7d=+0.001 | Chg30d=-0.117 | Revisions Net=-8 | Growth EPS=+8.5% | Growth Revenue=+5.7%
[Analyst] Revisions Ratio: -0.62 (4 Up / 17 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.3% (Discount Rate 7.9% - Earnings Yield 3.7%)
[Growth] Growth Spread = +2.5% (Analyst 6.7% - Implied 4.3%)